What we know about the Alzheimer's drug Health Canada approved
October 29, 2025
Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's disease, raising questions about its effectiveness and availability in Canada.
Unpublished Newswire
For weeks, David Piccini has been under growing pressure for the controversial retraining scheme, which the auditor general determined was 'not fair, transparent or accountable.'
November 3, 2025 - 12:38 | Isaac Callan | Global News - Ottawa
Quebecers went to the polls in provincewide municipal elections Sunday, with close races and some turnover across the Outaouais region.
November 3, 2025 - 12:07 | | CBC News - Ottawa
The Ottawa Citizen Best Public Service Workplaces 2025 used 10 key performance indicators (KPIs) to rank 84 federal organizations. Read More
November 3, 2025 - 11:00 | Alex Robinson | Ottawa Citizen
Comments
Be the first to comment